The study’s authors surveyed 20 clinicians, reviewed literature, and used their experiences to put together best practices when it comes to hard conversations between doctors and patients.
Indeed they have even become “hyped” and patient organisations and doctors are faced with challenging conversations with people with blood cancer, as CAR-T therapies are still only approved ...